Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.47Price to Book
VS
Market
Sector
Industry
History
$ 1.05Close
$ 0.72 - $ 1.6 52-Week Range
Ticker Information
Ticker
TXMDCompany Name
THERAPEUTICSMD INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQTHERAPEUTICSMD INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TXMD - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 27.29M | $ 12.79M | 0.47 |
| 3/31/2025 | $ 26.74M | $ 17.59M | 0.66 |
| 12/31/2024 | $ 27.37M | $ 12.15M | 0.44 |
| 9/30/2024 | $ 27.09M | $ 17.3M | 0.64 |
| 6/30/2024 | $ 27.67M | $ 19.26M | 0.7 |
| 3/31/2024 | $ 28.66M | $ 23.41M | 0.82 |
| 12/31/2023 | $ 29.29M | $ 26.41M | 0.9 |
| 9/30/2023 | $ 28.05M | $ 21.26M | 0.76 |
| 6/30/2023 | $ 31.2M | $ 40.71M | 1.31 |
| 3/31/2023 | $ 32.02M | $ 45.05M | 1.41 |
Key Performance Insights, Last 5 Years
- THERAPEUTICSMD INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, THERAPEUTICSMD INC's average P/B has been 0.83.
- The median P/B for THERAPEUTICSMD INC during this period was 0.76
- THERAPEUTICSMD INC reached its highest P/B over the past 5 years at 1.41.
- The lowest P/B recorded by THERAPEUTICSMD INC in the same timeframe 0.44
THERAPEUTICSMD INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for THERAPEUTICSMD INC is calculated as follows: Market Cap [ $ 414.67M ] / Equity [ $ -116.03M ]
(=) P/B [ 0 ] TXMD - Price to Book, Last 5 years
0.44
Minimum
Dec 31, 2024
1.41
Maximum
Mar 31, 2023
0.83
Average
0.76
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |